• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抵抗综合征的临床特征:日本全国性调查。

Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan.

机构信息

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan.

Division of Diabetes, Metabolism and Endocrinology, Iwate Medical University, Morioka, Japan.

出版信息

J Diabetes Investig. 2020 May;11(3):603-616. doi: 10.1111/jdi.13171. Epub 2019 Dec 5.

DOI:10.1111/jdi.13171
PMID:31677333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7232299/
Abstract

AIMS/INTRODUCTION: Insulin resistance syndrome (IRS) of type A or B is triggered by gene abnormalities of or autoantibodies to the insulin receptor, respectively. Rabson-Mendenhall/Donohue syndrome is also caused by defects of the insulin receptor gene (INSR), but is more serious than type A IRS. Here, we carried out a nationwide survey of these syndromes in Japan.

MATERIALS AND METHODS

We sent questionnaires to a total of 1,957 academic councilors or responsible individuals at certified facilities of the Japan Diabetes Society, as well as at the department pediatrics or neonatology in medical centers with >300 beds.

RESULTS

We received 904 responses with information on 23, 30 and 10 cases of type A or B IRS and Rabson-Mendenhall/Donohue syndrome, respectively. Eight cases with type A IRS-like clinical features, but without an abnormality of INSR, were tentatively designated type X IRS, with five of these cases testing positive for PIK3R1 mutations. Fasting serum insulin levels at diagnosis (mean ± standard deviation) were 132.0 ± 112.4, 1122.1 ± 3292.5, 2895.5 ± 3181.5 and 145.0 ± 141.4 μU/mL for type A IRS, type B IRS, Rabson-Mendenhall/Donohue syndrome and type X IRS, respectively. Type A and type X IRS, as well as Rabson-Mendenhall/Donohue syndrome were associated with low birthweight. Type B IRS was diagnosed most frequently in older individuals, and was often associated with concurrent autoimmune conditions and hypoglycemia.

CONCLUSIONS

Information yielded by this first nationwide survey should provide epidemiological insight into these rare conditions and inform better healthcare for affected patients.

摘要

目的/引言:A 型或 B 型胰岛素抵抗综合征(IRS)分别由胰岛素受体的基因异常或自身抗体引起。拉布森-门登霍尔/多诺霍综合征也是由胰岛素受体基因(INSR)缺陷引起的,但比 A 型 IRS 更严重。在这里,我们对日本的这些综合征进行了全国性调查。

材料和方法

我们向日本糖尿病学会认证机构的总共 1957 名学术顾问或负责人,以及 300 张以上病床的医疗中心的儿科或新生儿科部门,发送了问卷。

结果

我们收到了 904 份回复,其中有 23 例、30 例和 10 例 A 型或 B 型 IRS 和拉布森-门登霍尔/多诺霍综合征的信息。8 例具有 A 型 IRS 样临床特征,但无 INSR 异常,暂定为 X 型 IRS,其中 5 例 PIK3R1 突变阳性。诊断时的空腹血清胰岛素水平(平均值±标准差)分别为 132.0±112.4、1122.1±3292.5、2895.5±3181.5 和 145.0±141.4μU/mL,用于 A 型 IRS、B 型 IRS、拉布森-门登霍尔/多诺霍综合征和 X 型 IRS。A 型和 X 型 IRS 以及拉布森-门登霍尔/多诺霍综合征与低出生体重有关。B 型 IRS 最常发生在年龄较大的个体中,常伴有自身免疫性疾病和低血糖。

结论

这项首次全国性调查提供的信息应能深入了解这些罕见疾病的流行病学,并为受影响患者提供更好的医疗保健。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/989a/7232299/ec6458888040/JDI-11-603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/989a/7232299/eef1370632f2/JDI-11-603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/989a/7232299/7d7deee17698/JDI-11-603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/989a/7232299/ec6458888040/JDI-11-603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/989a/7232299/eef1370632f2/JDI-11-603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/989a/7232299/7d7deee17698/JDI-11-603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/989a/7232299/ec6458888040/JDI-11-603-g003.jpg

相似文献

1
Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan.胰岛素抵抗综合征的临床特征:日本全国性调查。
J Diabetes Investig. 2020 May;11(3):603-616. doi: 10.1111/jdi.13171. Epub 2019 Dec 5.
2
Clinical and Functional Characterization of Novel INSR Variants in Two Families With Severe Insulin Resistance Syndrome.两家族严重胰岛素抵抗综合征中新型 INSR 变异的临床和功能特征。
Front Endocrinol (Lausanne). 2021 Apr 29;12:606964. doi: 10.3389/fendo.2021.606964. eCollection 2021.
3
New classification and diagnostic criteria for insulin resistance syndrome.胰岛素抵抗综合征的新分类和诊断标准。
Endocr J. 2022 Feb 28;69(2):107-113. doi: 10.1507/endocrj.EJ21-0725. Epub 2022 Feb 1.
4
One Novel 2.43Kb Deletion and One Single Nucleotide Mutation of the Gene in a Chinese Neonate with Rabson-Mendenhall Syndrome.一名患有拉布森-门登霍尔综合征的中国新生儿中该基因的一个新型2.43Kb缺失和一个单核苷酸突变。
J Clin Res Pediatr Endocrinol. 2018 Jun 1;10(2):183-187. doi: 10.4274/jcrpe.5080. Epub 2017 Oct 30.
5
Functional characterization of insulin receptor gene mutations contributing to Rabson-Mendenhall syndrome - phenotypic heterogeneity of insulin receptor gene mutations.胰岛素受体基因突变导致 Rabson-Mendenhall 综合征的功能特征 - 胰岛素受体基因突变的表型异质性。
Endocr J. 2011;58(11):931-40. doi: 10.1507/endocrj.ej11-0032. Epub 2011 Aug 23.
6
Identification of a Novel Homozygous INSR Variant in a Patient with Rabson-Mendenhall Syndrome from the United Arab Emirates.在一名来自阿拉伯联合酋长国的患有拉布森-门登霍尔综合征患者中鉴定出一种新型纯合INSR变异体。
Horm Res Paediatr. 2017;87(1):64-68. doi: 10.1159/000447090. Epub 2016 Jun 22.
7
Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?六例严重胰岛素抵抗(SIR)伴胰岛素受体突变:巴特样综合征是先天性 SIR 的特征吗?
Acta Diabetol. 2013 Dec;50(6):951-7. doi: 10.1007/s00592-013-0490-x. Epub 2013 Jul 4.
8
INSR novel mutations identified in a Chinese family with severe INSR-related insulin resistance syndromes: A case report.在一个中国家族中发现的与严重胰岛素受体相关的胰岛素抵抗综合征相关的 INSR 新突变:一例报告。
Medicine (Baltimore). 2022 Dec 9;101(49):e32266. doi: 10.1097/MD.0000000000032266.
9
Use of a Sodium-Glucose Cotransporter 2 Inhibitor, Empagliflozin, in a Patient with Rabson-Mendenhall Syndrome.钠-葡萄糖协同转运蛋白2抑制剂恩格列净在一名患有拉布森-门登霍尔综合征患者中的应用。
Horm Res Paediatr. 2021;94(7-8):313-316. doi: 10.1159/000519613. Epub 2021 Sep 22.
10
A novel homozygous missense mutation in the insulin receptor gene results in an atypical presentation of Rabson-Mendenhall syndrome.胰岛素受体基因中的一种新型纯合错义突变导致了拉布森-门登霍尔综合征的非典型表现。
Eur J Med Genet. 2016 Jan;59(1):16-9. doi: 10.1016/j.ejmg.2015.11.015. Epub 2015 Dec 9.

引用本文的文献

1
Management of pregnancy with metformin: Case reports for genetic insulin resistance syndrome and a literature review for gestational and type 2 diabetes.二甲双胍治疗妊娠:遗传性胰岛素抵抗综合征的病例报告及妊娠期和2型糖尿病的文献综述
J Diabetes Investig. 2025 Sep;16(9):1663-1669. doi: 10.1111/jdi.70105. Epub 2025 Jun 30.
2
Severe Insulin Resistance Syndromes: Clinical Spectrum and Management.严重胰岛素抵抗综合征:临床谱与管理
Int J Mol Sci. 2025 Jun 13;26(12):5669. doi: 10.3390/ijms26125669.
3
A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes.

本文引用的文献

1
Clinical characteristics of adolescent cases with Type A insulin resistance syndrome caused by heterozygous mutations in the β-subunit of the insulin receptor (INSR) gene.胰岛素受体(INSR)β亚单位基因杂合突变致青少年 A 型胰岛素抵抗综合征的临床特征。
J Diabetes. 2019 Jan;11(1):46-54. doi: 10.1111/1753-0407.12797. Epub 2018 Jul 4.
2
Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.柴朴汤作为B型胰岛素抵抗综合征的一种可能疗法:柴朴汤治疗后抗胰岛素受体抗体消失及血糖控制显著改善
Intern Med. 2018 Aug 15;57(16):2359-2363. doi: 10.2169/internalmedicine.0523-17. Epub 2018 Mar 9.
3
一例糖尿病发病19年后诊断出的携带新基因突变的SHORT综合征病例。
J Diabetes Investig. 2025 Aug;16(8):1561-1565. doi: 10.1111/jdi.70088. Epub 2025 May 27.
4
PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis.胰岛素抵抗或生长发育迟缓个体中的PIK3R1突变:病例系列及计算机模拟功能分析
J Diabetes Investig. 2025 Aug;16(8):1526-1534. doi: 10.1111/jdi.70062. Epub 2025 May 27.
5
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02).一项评估恩格列净治疗伴胰岛素抵抗的难治性糖尿病长期安全性的多中心、开放标签、单臂临床试验(EMPIRE-02)。
J Diabetes Investig. 2024 Sep;15(9):1211-1219. doi: 10.1111/jdi.14226. Epub 2024 May 4.
6
Diabetes mellitus with severe insulin resistance in a young male patient with a heterozygous pathogenic frameshift variant.一名年轻男性患者患有杂合致病性移码变异,伴有严重胰岛素抵抗的糖尿病。
Clin Pediatr Endocrinol. 2024;33(2):87-93. doi: 10.1297/cpe.2023-0081. Epub 2024 Feb 23.
7
Identification of causative gene variants for patients with known monogenic diabetes using a targeted next-generation sequencing panel in a single-center study.在一项单中心研究中,使用靶向新一代测序panel鉴定已知单基因糖尿病患者的致病基因变异。
Diabetol Int. 2023 Nov 15;15(2):203-211. doi: 10.1007/s13340-023-00669-3. eCollection 2024 Apr.
8
A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01).恩格列净治疗伴有胰岛素抵抗的难治性糖尿病的疗效和安全性多中心、开放标签、单臂试验(EMPIRE-01)
Diabetes Ther. 2024 Feb;15(2):533-545. doi: 10.1007/s13300-023-01526-x. Epub 2024 Jan 13.
9
Insulin signaling and its application.胰岛素信号转导及其应用。
Front Endocrinol (Lausanne). 2023 Aug 17;14:1226655. doi: 10.3389/fendo.2023.1226655. eCollection 2023.
10
A Qualitative Research Study of Experiences and Perceptions of People Living with Insulin Resistance Syndrome or Lipoatrophic Diabetes in Japan.一项关于日本胰岛素抵抗综合征或脂肪萎缩性糖尿病患者经历与认知的定性研究。
Diabetes Ther. 2023 Aug;14(8):1345-1356. doi: 10.1007/s13300-023-01412-6. Epub 2023 Jun 8.
Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor.
使用钠-葡萄糖共转运蛋白 2 抑制剂治疗 1 例由于 PIK3R1 突变引起的严重胰岛素抵抗病例。
J Diabetes Investig. 2018 Sep;9(5):1224-1227. doi: 10.1111/jdi.12825. Epub 2018 Mar 25.
4
A follow-up during puberty in a Japanese girl with type A insulin resistance due to a novel mutation in .一名因[具体基因]新突变导致A型胰岛素抵抗的日本女孩在青春期的随访情况。 (注:原文中“due to a novel mutation in.”后面似乎缺少具体基因信息)
Clin Pediatr Endocrinol. 2018;27(1):53-57. doi: 10.1297/cpe.27.53. Epub 2018 Jan 30.
5
Hyperinsulinemia and Insulin Receptor Gene Mutation in Nonobese Healthy Subjects in Japan.日本非肥胖健康受试者中的高胰岛素血症与胰岛素受体基因突变
J Endocr Soc. 2017 Oct 12;1(11):1351-1361. doi: 10.1210/js.2017-00332. eCollection 2017 Nov 1.
6
Structural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance.导致严重胰岛素抵抗的胰岛素受体(INSR)突变的结构基础及基因型-表型相关性
Diabetes. 2017 Oct;66(10):2713-2723. doi: 10.2337/db17-0301. Epub 2017 Aug 1.
7
[Case Report; A case of type B insulin-resistance syndrome ameliorated with immune-suppression therapies].[病例报告;1例经免疫抑制治疗改善的B型胰岛素抵抗综合征病例]
Nihon Naika Gakkai Zasshi. 2016 Apr 10;105(4):710-4. doi: 10.2169/naika.105.710.
8
Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report.根除幽门螺杆菌感染后用多种免疫抑制剂成功治疗的硬皮病合并B型胰岛素抵抗综合征:一例报告
BMC Endocr Disord. 2016 May 3;16(1):20. doi: 10.1186/s12902-016-0099-5.
9
PI3-kinase mutation linked to insulin and growth factor resistance in vivo.PI3激酶突变与体内胰岛素和生长因子抵抗相关。
J Clin Invest. 2016 Apr 1;126(4):1401-12. doi: 10.1172/JCI84005. Epub 2016 Mar 14.
10
Efficacy of oral glucocorticoid and cyclosporine in a case of rituximab-refractory type B insulin resistance syndrome.口服糖皮质激素和环孢素治疗利妥昔单抗难治性B型胰岛素抵抗综合征1例的疗效
J Diabetes Investig. 2015 Nov;6(6):734-8. doi: 10.1111/jdi.12337. Epub 2015 Mar 13.